Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-20-001327
Filing Date
2020-02-10
Accepted
2020-02-10 12:29:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 filing.txt SC 13G/A 6939
  Complete submission text file 0000315066-20-001327.txt   8543
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Subject) CIK: 0001629137 (see all company filings)

EIN.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88976 | Film No.: 20590784
SIC: 2834 Pharmaceutical Preparations